GanoderenicacidA , ≥98% , 100665-40-5
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB960.00 | In Stock |
|
| 5mg | RMB2400.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Boiling point: | 700.3±60.0 °C(Predicted) |
| Density | 1.24±0.1 g/cm3(Predicted) |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. |
| form | Powder |
| pka | 4.65±0.23(Predicted) |
| color | White to off-white |
| InChIKey | OVUOUFPIPZJGME-UHFFFAOYSA-N |
| SMILES | CC12C(CC(C(C)=CC(=O)CC(C)C(=O)O)C1(CC(=O)C1C3(CCC(=O)C(C)(C)C3CC(O)C2=1)C)C)O |
Description and Uses
Ganoderenic acid A is a triterpenoid originally isolated from G. lucidum that has enzyme inhibitory activities. It is an inhibitor of β-glucuronidase (IC50 = 0.12 mg/ml in rat liver microsomes). Ganoderenic acid A (100 mg/kg) reduces increases in serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) in a rat model of liver injury induced by carbon tetrachloride (CCl4). It also inhibits aldose reductase by 54.2% when used at a concentration of 100 μg/ml.
Carbidopa (monohydrate) (Standard) is the analytical standard of Carbidopa (monohydrate). This product is intended for research and analytical applications. Carbidopa ((S)-(-)-Carbidopa) monohydrate, a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa monohydrate is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa monohydrate inhibits pancreatic cancer cell and tumor growth.
